CBD and Drug Interactions: What You Need to Know Before Starting
Affiliate Disclosure: This post may contain affiliate links. We may earn a commission if you purchase through our links at...
Read moreLupus is a chronic autoimmune disease that causes inflammation throughout the body. Many lupus patients seek complementary approaches to manage symptoms like joint pain, fatigue, and skin rashes. CBD (cannabidiol) has shown promise in preliminary research for its anti-inflammatory and immune-modulating properties. While CBD is not a treatment for lupus, some patients report it helps manage specific symptoms when used alongside medical care.
If considering CBD for lupus symptoms, start with a low dose (5-10mg daily) and gradually increase as tolerated. Most users report symptom relief at 10-25mg per day, though individual responses vary. Always consult your rheumatologist before adding CBD, especially if you’re taking immunosuppressants or biologics. Some lupus medications may interact with CBD, so professional guidance is essential.
For lupus-related pain and inflammation, consider full-spectrum or broad-spectrum CBD oils with third-party lab testing. Topical CBD creams work well for localized joint pain and skin flares. Soft gels offer convenient dosing for daily management. Look for products from manufacturers who provide certificates of analysis (COA) and source hemp from reputable growers.
Current research on CBD and autoimmune disease is limited but encouraging. Studies published in journals like Frontiers in Immunology show CBD’s potential to reduce inflammatory cytokines implicated in lupus progression. However, more human clinical trials are needed. Always stay informed by your medical team about the latest research and how it applies to your specific lupus diagnosis.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more